DLA Piper's At the Intersection of Science and Law

A Life Sciences podcast by DLA Piper

0.0 • 0 ratings

Want connect with DLA Piper and email directly about potential partnerships?

In DLA Piper’s At the Intersection of Science and Law podcast, members of the firm’s Life Sciences team explore the connection between science and the law in areas that include AI and drug discovery, mRNA technology, and the regulatory implications of new drugs and devices.

Recent Episodes

Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches
Published: November 15, 2024
Listen
Life sciences companies and the risks posed by the mifepristone litigation
Published: May 19, 2023
Listen
Trade secrets protection in the life sciences sector
Published: April 12, 2023
Listen
Cross-border considerations for privacy in clinical trials
Published: February 6, 2023
Listen
Global Life Sciences Supply Chain Insights
Published: November 3, 2022
Listen
AI risk assessments: Future-proofing your innovation when rules can change mid-game
Published: September 6, 2022
Listen
The rise of global telehealth
Published: June 1, 2022
Listen
Advising the advisor: Tips for navigating the life sciences and regulatory environment
Published: April 18, 2022
Listen
The moral imperative: Balancing innovation, regulation and prescription drug availability
Published: March 21, 2022
Listen
Incentivizing diverse representation in clinical trials
Published: March 2, 2022
Listen

Listen to All Episodes From DLA Piper's At the Intersection of Science and Law